Literature DB >> 1628323

Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells.

B K Gillard1, L T Thurmon, D M Marcus.   

Abstract

We reported recently that two glycosphingolipids (GSLs), globoside (Gb4) and ganglioside GM3, colocalized with vimentin intermediate filaments of human umbilical vein endothelial cells. To determine whether this association is unique to endothelial cells or to vimentin, we analyzed a variety of cell types. Double-label immunofluorescent staining of fixed, permeabilized cells, with and without colcemid treatment, was performed with antibodies against glycolipids and intermediate filaments. Globoside colocalized with vimentin in human and mouse fibroblasts, with desmin in smooth muscle cells, with keratin in keratinocytes and hepatoma cells, and with glial fibrillary acidic protein (GFAP) in glial cells. Globoside colocalization was detected only with vimentin in MDCK and HeLa cells, which contain separate vimentin and keratin networks. GM3 ganglioside also colocalized with vimentin in human fibroblasts. Association of other GSLs with intermediate filaments was not detected by immunofluorescence, but all cell GSLs were detected in cytoskeletal fractions of metabolically labelled endothelial cells. These observations indicate that globoside colocalizes with vimentin, desmin, kertain and GFAP, with a preference for vimentin in cells that contain both vimentin and keratin networks. The nature of the association is not yet known. Globoside and GM3 may be present in vesicles associated with intermediate filaments (IF), or bound directly to IF or IF associated proteins. The prevalence of this association suggests that colocalization of globoside with the intermediate filament network has functional significance. We are investigating the possibility that intermediate filaments participate in the intracellular transport and sorting of glycosphingolipids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628323     DOI: 10.1002/cm.970210402

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  9 in total

1.  Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigs.

Authors:  T E Waddell; B L Coomber; C L Gyles
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

2.  Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.

Authors:  Jan Bieri; Carlos Ros
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  CDw60: an antigen expressed in many normal tissues and in some tumours.

Authors:  A Gocht; A Gadatsch; G Rutter; B Kniep
Journal:  Histochem J       Date:  2000-07

4.  Differential effects of synthetic sphingosine derivatives on melanoma cell motility, growth, adhesion and invasion in vitro.

Authors:  C Helige; J Smolle; R Fink-Puches; R Hofmann-Wellenhof; E Hartmann; T Bär; R R Schmidt; H A Tritthart
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

Review 5.  Sialidase and malignancy: a minireview.

Authors:  Taeko Miyagi; Tadashi Wada; Kazunori Yamaguchi; Keiko Hata
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 6.  Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.

Authors:  Ivan O Potapenko; Vilde D Haakensen; Torben Lüders; Aslaug Helland; Ida Bukholm; Therese Sørlie; Vessela N Kristensen; Ole C Lingjaerde; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2009-12-11       Impact factor: 6.603

7.  Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected].

Authors:  T Kanda; H Yoshino; T Ariga; M Yamawaki; R K Yu
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

8.  Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis.

Authors:  K N Burger; P van der Bijl; G van Meer
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

9.  My career as an immunoglycobiologist.

Authors:  Donald M Marcus
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.